glp 1 receptor agonists and dpp 4 inhibitors Dipeptidyl peptidase in the treatment of type 2 diabetes mellitus The Current Drug Treatment Landscape

J Chem Neuroanat 35:202215 Cross D, Alessi DR, Cohen P et al (1995) Inhibition of glycogen synthase kinase-3 by insulin mediated by protein kinase B

Mt hp c 5 v, l 30 vin nn mu trng

In fact, a low TAC value can indicate a stable clinical condition, an inability to respond to the increasing production of radicals, or high antioxidant consumption due to OS

doi: 10.3389/fphar.2025.1560567 Received 14 January 2025 Accepted 28 March 2025 Published 16 April 2025 Volume 16 - 2025 Edited by Duuamene Nyimanu, University of Kansas Medical Center, United States Reviewed by Hao Du, Yale University, United States Ashish Dhayani, University of Pittsburgh, United States Updates Copyright 2025 Zhao, Jin, Zhao, Wang, Zhao, Xue, Qiao, Qu, Han and Tao

These observations reinforce the need for well-designed randomised controlled trials (RCTs) to validate the findings and expand the evidence base